A carregar...
A phase II irinotecan–cisplatin combination in advanced pancreatic cancer
We report a cisplatin and irinotecan combination in patients with biopsy-proven advanced pancreatic adenocarcinoma. Patients were selected from a specialist centre and required good performance status (KPS>70%), measurable disease on CT scan, and biochemical and haematological parameters within n...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2003
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2394443/ https://ncbi.nlm.nih.gov/pubmed/14612893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601377 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|